SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001510964-23-000026
Filing Date
2023-06-05
Accepted
2023-06-05 16:52:45
Documents
13
Period of Report
2023-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cvsi-20230601.htm   iXBRL 8-K 49457
2 EX-10.1 a2023plan.htm EX-10.1 191926
  Complete submission text file 0001510964-23-000026.txt   396123

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cvsi-20230601.xsd EX-101.SCH 1921
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cvsi-20230601_lab.xml EX-101.LAB 21368
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cvsi-20230601_pre.xml EX-101.PRE 10992
7 EXTRACTED XBRL INSTANCE DOCUMENT cvsi-20230601_htm.xml XML 9105
Mailing Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126
Business Address 9530 PADGETT STREET SUITE 107 SAN DIEGO CA 92126 866-290-2157
CV Sciences, Inc. (Filer) CIK: 0001510964 (see all company filings)

IRS No.: 800944970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54677 | Film No.: 23993383
SIC: 2834 Pharmaceutical Preparations